Lab Corp. (NYSE: LH) announced that Deborah Keller will succeed Joseph Herring as Chief Executive Officer of Covance Drug Development ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Changes Management Comments

LabCorp Announces New Covance LeadershipJuly 28, 2015 7:32 AM Form 8-K LABORATORY CORP OF AMERI For: Jul 28July 28, 2015 7:06 AM Form 8-K LABORATORY CORP OF AMERI For: Jul 28July 28, 2015 7:05 AM Lab Corp. (LH) Tops Q2 EPS by 6c; Boosts FY15 EPS OutlookJuly 28, 2015 7:03 AM